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Abstract
There are two main classes of natural killer (NK) cell receptors in mammals, the killer cell immunoglobulin-like receptors (KIR)
and the structurally unrelated killer cell lectin-like receptors (KLR). While KIR represent the most diverse group of NK
receptors in all primates studied to date, including humans, apes, and Old and New World monkeys, KLR represent the
functional equivalent in rodents. Here, we report a first digression from this rule in lemurs, where the KLR (CD94/NKG2)
rather than KIR constitute the most diverse group of NK cell receptors. We demonstrate that natural selection contributed to
such diversification in lemurs and particularly targeted KLR residues interacting with the peptide presented by MHC class I
ligands. We further show that lemurs lack a strict ortholog or functional equivalent of MHC-E, the ligands of non-
polymorphic KLR in ‘‘higher’’ primates. Our data support the existence of a hitherto unknown system of polymorphic and
diverse NK cell receptors in primates and of combinatorial diversity as a novel mechanism to increase NK cell receptor
repertoire.
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Introduction
Natural killer (NK) cells are bone marrow-derived lymphocytes
that form an essential part of the immune response against
pathogens and are involved in the elimination of tumour cells.
Equipped with a diverse array of germline-encoded receptors that
are able to mediate inhibitory or activating signals [1], NK cells
scan other cells for the presence of ligands of these receptors [2].
Activation of NK cells is typically achieved by discontinuation of
inhibitory signalling and involvement of activating receptors,
resulting in cytokine release or killing of target cells [2–4]. Most
NK cell receptors interact with members of the MHC class I
protein family and either belong to the killer cell lectin-like
receptors (KLR) of the C-type lectin-like family such as CD94,
NKG2, or Ly49, or the killer cell immunoglobulin-like (KIR)
receptors, which are encoded in the natural killer complex (NKC)
and leukocyte receptor complex (LRC), respectively [1]. Both NKC
and LRC contain inhibitory and activating NK cell receptors.
Inhibitory receptors are characterised by the presence of
immunoreceptor tyrosine-based inhibitory motifs (ITIM) in the
cytoplasmic tail, whereas activating receptors lack ITIMs and
instead contain a positively charged amino acid (arginine or lysine)
in their transmembrane region, thereby associating with signalling
adaptor molecules DAP10, DAP12 or FccR [2].
The polymorphic NK cell receptors are represented by KIR in
humans, apes, Old World and New World monkeys [5–7] and
KLR (Ly49 molecules) in rodents [8]. These two receptor systems
are not structurally related, but have similar functions: interaction
with MHC class I molecules and regulation of NK cell activity [2].
Due to these functional constraints, KIR and Ly49 genes have to
keep pace with the rapidly evolving and polymorphic class I genes
[9] and it has been shown that combinations of this highly
complex and polymorphic genetic system of NK cell receptors and
their MHC class I ligands can significantly influence susceptibility
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and resistance to infectious and malignant diseases, autoimmune
disorders, and reproduction [10]. In contrast to KIR and Ly49,
another genetic system of MHC class I-binding NK cell receptors
has been kept conserved in primates (hominoids, Old World and
New World monkeys) [11] and rodents [12], the CD94 and
NKG2 molecules, which also belong to the KLR family. The
CD94 molecule can either pair with the inhibitory NKG2A or the
activating NKG2C and NKG2E molecules and these heterodi-
meric NK cell receptors specifically recognise conserved nonclas-
sical class I molecules, HLA-E in humans [13] and H2-Qa1 in
mice [14]. These nonclassical class I molecules bind peptides
derived from signal sequences of certain class I molecules [15],
thereby monitoring putative downregulation of the corresponding
class I molecules mediated by pathogens as part of their immune
evasion strategy.
Various NK cell receptors (CD94/NKG2, KIR, Ly49L) have
been identified in different nonhuman primates, and rapid
evolution in particular of the KIR genes was reported [16]. Yet,
two questions remain open: how far can we trace back KIR3DL
diversification and what was the NK cell receptor content in the
ancestor of all primates? We report here that strepsirrhine
primates such as lemurs have evolved a ‘third way’ of a diverse
NK cell receptor system and exhibit highly diversified, positively
selected CD94/NKG2 receptors. This NK cell receptor system is
further characterised by combinatorial diversity.
Results
In the absence of a formal taxonomic designation, we refer to
strepsirrhines (lemurs, galagos, lorises) and tarsier as ‘lower’
primates and to humans, apes, Old and New World monkeys as
‘higher’ primates throughout the manuscript.
Unusual organisation of the LRC, NKC, and MHC in
‘‘lower’’ primates
Clones containing the LRC, NKC, and MHC genomic regions
were isolated from a BAC library of the grey mouse lemur
(Microcebus murinus). Nineteen BAC clones from the LRC region
were identified and three clones covering the KIR-LILR subregion
were sequenced: one clone contains the NCR1, FCAR, and LILR
genes in addition to a KIR3DP pseudogene mapping between
FCAR and the LILR gene cluster, and the other two clones both
include LILR genes and a single copy of the KIR3DX1 [17] gene
(Figure 1A). Similar to all other primate KIR3DX1 genes, the two
lemur copies, of which only one is intact, also lack the MLTD1
repetitive elements in intron 3. The intact copy is transcribed in
lemur PBMC and alternatively spliced (Figure S1); the other locus
(KIR3DX1P) is a fragmented pseudogene. In contrast, KIR3DP is
characterised by the presence of KIR3DL-typical repetitive
elements such as MLT1D/LTR33A, MSTB1, MER70B [7] and is
thus the only representative of the KIR3DL lineage in the grey
mouse lemur. The repetitive elements flanking KIR3DP are found
in the ‘outer’ human KIR genes KIR3DL3 and KIR3DL2 (data not
shown), suggesting that the lemur KIR3DP is equivalent to all
‘higher’ primate KIR genes. Thus, the only functional KIR in the
mouse lemur genome is represented by KIR3DX1, a KIR gene of
unknown function [17].
Unlike the KIR region, the CD94-Ly49L genomic interval of the
grey mouse lemur NKC showed amplifications of the CD94 and
NKG2 genes (Figure 1B), which accounted for its 1.5 times
increased size compared to humans. Only two genes in this region
represent one-to-one orthologs of ‘higher’ primate genes: NKG2D
and Ly49L. Further investigations of the three mouse lemur CD94
genes indicate they encode typical CD94 receptor structures but
their amino acid sequences show considerable diversity, differing
by 23–24% among each other (Figure S2). Such level of
divergence is significantly higher than in ‘higher’ primates, as
human and common marmoset monkey CD94 sequences differ
only by 13% for example [11]. Furthermore, eight NKG2-related
genes were identified (Figure 1B), of which five are functional
genes (Figure S3) and three are pseudogenes. The NKG2
molecules show different combinations of functionally relevant
motifs: ITIM, positively charged residue in the transmembrane
region, and the YxxM motif, which is a recognition site for the p85
subunit of phosphatidylinositol 3-kinase (PI3K). Allelic substitu-
tions affect the presence of ITIM and YxxM motifs in NKG2-2 and
NKG2-3 (Figure S3). These findings suggest that the mouse lemur
NKG2 receptors are functionally complex, with inhibitory and
activating properties.
BAC clones from the MHC class I and class II regions could be
mapped to the short arm of mouse lemur chromosome 6 by
fluorescence in-situ hybridisation (FISH) (Figure 2). Whereas the
class II region is conserved (Averdam et al., manuscript in
preparation), the linked class I gene-containing regions of the
mouse lemur MHC lack any functional class I genes as the four
identified class I genes and the single MIC gene all represent
pseudogenes (Figure 1C). Remarkably, even MHC-E and MHC-F,
the only two conserved MHC class I genes of ‘higher’ primates, are
missing in the mouse lemur MHC. Interestingly, our screening of
the mouse lemur BAC library for MHC class I genes also identified
an unlinked genomic region that includes nine MHC class I genes.
Complete sequencing of this region revealed six genes encoding
functional MHC class I proteins, including putative alleles of the
previously described classical class I genes of the mouse lemur,
Mimu-W01 and Mimu-W04 [18] (Figure 1C). This class I gene
cluster maps to another chromosome, the long arm of mouse
lemur chromosome 26 (Figure 2), thus providing an additional
example of a mammalian species where MHC class I and class II
genes are not linked. A similar chromosomal splitting of class I
genes was found for a further lemur species, Coquerel’s giant
mouse lemur (Mirza coquereli) (Figure 2). The CD94 and NKG2
genes could be mapped to chromosome 7 in the giant mouse
Author Summary
Most receptors of natural killer (NK) cells interact with
highly polymorphic major histocompatibility complex
(MHC) class I molecules and thereby regulate the activity
of NK cells against infected or malignant target cells.
Whereas humans, apes, and Old and New World monkeys
use the family of killer cell immunoglobulin-like receptors
(KIR) as highly diverse NK cell receptors, this function is
performed in rodents by the diverse family of lectin-like
receptors Ly49. When did this functional separation occur
in evolution? We followed this by investigating lemurs,
primates that are distantly related to humans. We show
here that lemurs employ the CD94/NKG2 family as their
highly diversified NK cell receptors. The CD94/NKG2
receptors also belong to the lectin-like receptor family,
but are rather conserved in ‘‘higher’’ primates and rodents.
We could further demonstrate that lemurs have a single
Ly49 gene like other primates but lack functional KIR genes
of the KIR3DL lineage and show major deviations in their
MHC class I genomic organisation. Thus, lemurs have
evolved a ‘‘third way’’ of polymorphic and diverse NK cell
receptors. In addition, the multiplied lemur CD94/NKG2
receptors can be freely combined, thereby forming diverse
receptors. This is, therefore, the first description of some
combinatorial diversity of NK cell receptors.
Novel NK Cell Receptor System
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Figure 1. Comparison of human and grey mouse lemur LRC, NKC, and MHC genomic regions. Y denotes pseudogene (criteria based on:
premature stop codons, frameshift deletions/insertions, absence of essential coding/non-coding parts). (A) Sequenced BAC clones (GenBank
accession no. CR974412, CR974436, CR974413) of the LRC. Open rectangles denote KIR genes, filled rectangles all other genes. Arrows point to
corresponding KIR genes. No gene designations are shown for human KIR haplotypes. (B) Sequenced BAC clone contig of the NKC that constitute a
complete haplotype. Open rectangles denote NKG2 genes, grey rectangles CD94 genes, and filled rectangles all other genes. The order of BAC clones
in this CD94 to Ly49L genomic interval is: 50I2, 96C7, 146L20, and 1E15 (haplotype 1: GenBank accession no. FP236838). A second contig of BAC
clones includes the CD94-1-NKG2-8 interval represented by clones 481C2, 492D19, 489H5, and 222F7 (not shown) and constitutes a second
haplotype (GenBank accession no. FP236834). (C) Sequenced BAC clones (GenBank accession no. AB480748, FP236831, FP236832, FP236833,
FP236839) of the MHC class I gene regions. Class I genes of BAC clone CH257-465D12 that could not be assigned to an already known gene or allele,
are named according to their position on the BAC clone (numbers in parentheses). Putative alleles Mimu-W01 and Mimu-W04 are indicated. Open
rectangles denote MHC class I genes, grey rectangles MHC class II genes, and filled rectangles all other genes.
doi:10.1371/journal.pgen.1000688.g001
Novel NK Cell Receptor System
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Figure 2. Chromosomal localisation of lemur MHC and NK cell receptor genes. FISH using mouse lemur BACs containing MHC class I and
class II genes reveals a split of class I genes to chromosome 6 (GNL, TRIM39, TRIM26, ZNRD1, MOG, BAT1, MIC, POU5F1) and to chromosome 26
(ANKRD11, Mimu-W01, Mimu-W04) of Microcebus murinus. Nomenclature of M.murinus and M.coquereli chromosomes are according to Ref. [43] The
same split is shown for Mirza coquereli: ZNRD1 and MOG hybridise to chromosome 6 and ANKRD11, Mimu-W01, and Mimu-W04 to chromosome 26.
All tested MHC class II region genes (TAP2, DQ, DR, BTNL2) map to chromosome 6 in Microcebus murinus and Mirza coquereli, respectively. Note that
in both species secondary signals appear scattered along the X chromosome. In Mirza coquereli, KIR-including BAC CD257-37C10 hybridises to a
small acrocentric chromosome not identical with chromosome 26 and to the X chromosome, and NKG2-including BAC CH257-96C7 maps to
chromosome 7, which is orthologous to human chromosome 12. Note that further signals appear on the chromosome X.
doi:10.1371/journal.pgen.1000688.g002
Novel NK Cell Receptor System
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lemur, which corresponds to human chromosome 12, indicating
conserved synteny of the NKC region. The KIR3DX1P gene-
containing BAC was mapped to a small acrocentric chromosome
not identical with chromosome 26 (Figure 2).
Evolution of CD94/NKG2 and MHC class I genes in ‘‘lower’’
and ‘‘higher’’ primates
Using the mouse lemur NKC sequences as reference we
investigated corresponding cDNA sequences from the black-and-
white ruffed lemur (Varecia variegata), a species that diverged from
the grey mouse lemur about 43 million years ago (mya) [19]. A
single NKG2D, five CD94, nine NKG2 and two Ly49L cDNA
sequences were isolated from ruffed lemur PBMC by RT-PCR
cloning. The deduced amino acid sequences exhibit similar
functional features as described above for mouse lemur CD94
and NKG2 molecules (Figure S2, Figure S3). Two pairs of CD94
sequences (CD94-2*01, CD94-2*02, and CD94-3*01, CD94-3*02)
only differ by a few nucleotide substitutions and are, therefore,
regarded as alleles. Similarly, two allelic NKG2 (NKG2-6*01,
NKG2-6*02) and two allelic Ly49L (Ly49L*01, Ly49L*02) sequences
were isolated, so that the ruffed lemur NKC is estimated to possess
three CD94, eight NKG2 genes and single NKG2D and Ly49L genes.
Phylogenetic analyses of primate CD94 and NKG2 sequences
encoding the C-type lectin-like domain indicate that for both gene
families ‘lower’ and ‘higher’ primate sequences form their own
groups, indicating that diversification of CD94 and NKG2 occurred
in ‘lower’ primates after their separation with ‘higher’ primates
(Figures 3A and 3B). ‘Lower’ primate NKG2 sequences form three
groups, each with sequences from both lemurs, pointing to
duplications that preceded speciation of both lemurs (Figure 3B).
Similarly, in the largest of the three ‘lower’ primate NKG2 groups,
some gene sequences show species-specific clustering indicating
gene duplications following speciation of both lemurs. Such
patterns demonstrate that NKG2 gene duplications in ‘lower’
primates occurred both before and after the separation of the two
lemur species, a process similar to that seen for KIR in ‘higher’
primates and Ly49 in rodents [20]. In contrast to the C-type lectin-
like domain, NKG2 sequences encoding the stem, cytoplasmic, and
transmembrane part fall into two branches: one contains ‘lower’
and ‘higher’ primate inhibitory NKG2, the other one containing
‘lower’ and ‘higher’ primate activating NKG2, indicating that these
two types of sequences separated before the speciation between
‘higher’ and ‘lower’ primates (Figure 3C).
To determine whether amplification of CD94 genes is restricted
to strepsirrhine primates living in Madagascar (lemurs) or is
common to other ‘lower’ primates, we investigated the CD94
sequences of an African and an Asian primate, the potto
(Perodicticus potto) and the tarsier (Tarsius syrichta). Whereas the
potto belongs to the primate suborder Strepsirrhini, the tarsier is a
member of the other primate suborder, the Haplorrhini (tarsiers,
New and Old World monkeys, apes and human). Using all
available primate sequences as reference, generic primers were
constructed to amplify the region including exon 4, intron 4 and
exon 5 of CD94 and we characterised seven and nine different
CD94 sequences in potto and tarsier, respectively (Figure S4).
These findings thus indicate that CD94 gene amplification is not
restricted to lemurs, but can be found in other strepsirrhine
primates and even in a primate more closely related to humans
than to lemurs [21]. Insertions of repetitive elements of the Alu
family in intron 4 revealed additional information: whereas none
of the three mouse lemur CD94 genes contains any Alu element,
four of the seven potto sequences include an AluJo and all nine
tarsier sequences have an AluJb element (Figure S4). However, the
integration sites of these Alu elements differ between potto and
tarsier, indicating that integration events occurred after these
lineages diverged from each other. Hence, the amplification of
CD94 sequences occurred repeatedly and independently in ‘lower’
primates. The intron 4 sequences of human, rhesus macaque and
common marmoset CD94 share an AluSx integration (data not
shown), which is not present in ‘lower’ primates, further
supporting the monophyletic origin of ‘higher’ primate CD94.
While lemurs (and possibly other ‘lower’ primates) experienced
a diversification of the CD94/NKG2 receptor system, they appear
to lack MHC-E, the ligand of CD94/NKG2 in ‘higher’ primates,
as their MHC region lacks a class I gene where the MHC-E gene of
‘higher’ primates is located (Figure 1C). To investigate if any of the
grey mouse lemur MHC class I genes represents an ortholog or
functional equivalent of ‘higher’ primate MHC-E, we performed
phylogenetic analyses of primate MHC class I sequences. Analyses
of the full-length sequences and of the peptide-binding-domain
(PBD) alone, with or without the peptide binding residues (PBR)
indicate that ‘lower’ and ‘higher’ primate sequences form their
own groups (Figure 4A–4C, Figure S5). This demonstrates that
MHC class I diversification in ‘lower’ and ‘higher’ primates took
place in each taxonomic lineage after their separation and further
indicates that the duplication that gave rise to the MHC class I
genes on chromosome 26q occurred in the ‘lower’ primate lineage.
Similarly, analysis of the PBR revealed that the ‘higher’ primate
MHC-E sequences are more closely related to the rodent Qa1
group than to any of the ‘lower’ primate sequences (Figure 4D).
Thus, these findings indicate that the grey mouse lemur genome
neither encodes a strict orthologue (with a one-to-one relationship)
nor a functional homologue of MHC-E and confirm earlier data of
our group that ‘higher’ and ‘lower’ primate MHC class I genes lack
strict orthology [18].
NKC-encoded genes of ‘‘lower’’ primates are genetically
and functionally diverse
Our genomic analysis in one mouse lemur individual and cDNA
sequencing in three individuals (two mouse lemurs and one black-
and-white ruffed lemur) revealed that ‘lower’ primates experienced
a diversification of both CD94 and NKG2. Such diversification is in
contrast with the situation in ‘higher’ primates where CD94 is a
non-polymorphic, single-copy gene and where the NKG2 gene
family experienced limited diversification with moderate polymor-
phism. To investigate if such difference is the result of natural
selection favouring functional diversity in ‘lower’ but not in
‘higher’ primates, we compared the non-synonymous to synony-
mous substitution ratio rate (dN/dS) of CD94 and NKG2 sequences
of ‘lower’ and ‘higher’ primates (Table 1). This analysis shows that
‘lower’ primate CD94 sequences display highly significant evidence
of positive diversifying selection (a=0.001) with 15 positions
positively selected (posterior probability (PP).0.95). In contrast,
their ‘higher’ primate counterparts do not show any evidence of
positive selection (Table 1). A similar, yet not as marked, trend is
seen for NKG2 as ‘lower’ primate sequences show highly significant
evidence of positive diversifying selection (a=0.001), with six
positions being positively selected (PP.0.95) while in ‘higher’
primates the evidence was not as strong (a=0.01–0.05) and
limited to only one site (Table 1). Mapping of the 21 positively
selected sites in ‘lower’ primates on the three-dimensional model of
the human CD94/NKG2A heterodimer in contact with HLA-E
[22,23] suggests that many of these positions represent functionally
relevant sites (Figure 5A). Indeed, closer inspection revealed that
the distribution of these 21 positively selected sites in the CD94/
NKG2 lectin-like domains shows a significant bias (a=0.05) toward
the 54 sites involved in ligand-binding and/or dimer formation
(Table 2, Figure S6). Further dissection of this bias shows it is
Novel NK Cell Receptor System
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particularly marked for the 28 ligand-binding sites (a=0.01), but
not for the 30 sites involved in dimer formation. Within the ligand-
binding sites a significant bias toward the 7 sites contacting the
MHC class I peptide (a=0.003) was observed, but for the sites
contacting the MHC-class I heavy chain the bias was marginal
(a,0.06) (Table 2, Figure S6). Consistent with this, the four
CD94/NKG2 positively selected positions that contact the MHC
class I peptide account for 75% (9 out of 12) of all the contacts with
the peptide (Figure 5B). This analysis thus shows that the genomic
diversification of CD94/NKG2 in ‘lower’ primates was accompa-
nied by positive diversifying selection that particularly targeted the
sites contacting the MHC class I peptide. In ‘higher’ primates the
limited (NKG2) or lack of (CD94) genomic diversification was
accompanied by limited (NKG2) or lack of (CD94) sequence
diversification through positive diversifying selection.
To fully investigate the extent of allelic diversity of ‘lower’ primate
NKC genes we specifically amplified the exons encoding the lectin-
like domain of mouse lemur CD94, NKG2, and Ly49L genes in a
cohort of 46 free-living unrelated animals derived from the Kirindy
region in Madagascar [24]. Twelve animals were analysed for all
Figure 3. Major diversification of CD94 and NKG2 occurred in ‘‘lower’’ primates after their separation with ‘‘higher’’ primates.
Phylogenetic analyses of primate CD94 (A) and NKG2 (B) C-type lectin-like domain sequences and NKG2 stalk, transmembrane, cytoplasmic regions (C).
The tree topology obtained with the Neighbor-Joining (NJ) analysis was used for the display (with a midpoint rooting) and numbers at nodes indicate
support obtained for Bayesian, parsimony, and NJ methods (from top to bottom). Support is shown if Bayesian posterior probability (PP) $ 88% and
other methods bootstrap proportion (BP) $ 50% (at least 2 methods). Filled circles at nodes indicate PP . 95% and BP $ 80%. *: BP , 50 or PP, 80.
Mimu, Microcebusmurinus; Vava, Varecia variegata. Amaximum-likelihood analysis was also performed, and themaximum-likelihood bootstrap support
is indicated in parenthesis for two nodes.
doi:10.1371/journal.pgen.1000688.g003
Novel NK Cell Receptor System
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Figure 4. ‘‘Lower’’ primates lack a strict ortholog or functional equivalent of ‘‘higher’’ primate MHC-E. Phylogenetic analyses of MHC
class I genes with complete coding sequences (A), peptide binding domain (B), peptide binding domain excluding peptide binding residues (C) and
peptide binding residues only (D). A phylogenetic analysis of MHC class I genes with complete coding sequences excluding the peptide binding
residues was also conducted and the results are presented in Figure S5. Analysis and display are as described for Figure 3. Numbers as gene names
for MHC class I are the same as in Figure 1C. Non-primate sequences included are mouse (H2) and rat (RT1). Peptide binding residues were defined
according to Bjorkman et al. [44]. Patr, Pan troglodytes; Gogo, Gorilla gorilla; Hyla, Hylobates lar; Saoe, Saguinus oedipus; Sasc, Saimiri sciureus; Mamu,
Macaca mulatta; Mimu, Microcebus murinus; Aotr, Aotus trivirgatus; Caja, Callithrix jacchus; Pipi, Pithecia pithecia.
doi:10.1371/journal.pgen.1000688.g004
Novel NK Cell Receptor System
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genes and further 34 animals were additionally analysed for the
three CD94 genes. No presence/absence polymorphisms of grey
mouse lemur CD94 or NKG2 genes were observed in our cohort,
indicating that copy number variation similar to what is known for
human KIR and mouse/rat Ly49 haplotypes is not evident in grey
mouse lemur CD94/NKG2 haplotypes. Single nucleotide polymor-
phisms (SNPs) were detected for all genes and with the exception of
CD94-3 and NKG2D, all the NKC genes show an excess of non-
synonymous substitutions (Table S1). While 30% (71/236) of all the
codons forming the lectin-like domains of CD94 and NKG2 have
non-synonymous allelic polymorphisms in at least one of the ‘lower’
primate CD94 or NKG2 genes, 66% (47/71) of these codons are
neither sites involved in ligand binding or dimer formation nor
positions we detected as positively selected in our gene analysis.
Figure 5. Natural selection diversified ‘‘lower’’ primate CD94 and NKG2 sequences and particularly targeted the residues
interacting with the peptide presented by MHC class I ligands. (A) Positively selected sites of ‘lower’ primates CD94/NKG2 superimposed on
the three-dimensional structure of the human CD94/NKG2A/HLA-E complex [22,23]. The PDB file 3cdg was used and represented with PyMOL [45]. (B)
Top panel: CD94/NKG2 residues known to interact with MHC class I-bound peptide (based on human CD94/NKG2A/HLA-E). Positively selected
residues in ‘lower’ primates are shown in red. Peptide positions are indicated. Residue in italics indicates allelic substitutions were found at this site.
Bottom panel: ribbon diagram focused on the region where the interaction between CD94-NKG2A and HLA-E occurs; side chains are displayed.
doi:10.1371/journal.pgen.1000688.g005
Table 1. Natural selection diversified CD94 and NKG2 residues in ‘‘lower’’ primates, but not in ‘‘higher’’ primates.
Comparison 2Dl a
Proportion of
selected sites
dN/dS for
selected sites Positively selected sites (M8 p.0.95)
CD94 ‘Lower’ primates M1a vs. M2a 37.66 0.001 0.26 5.51
M8a vs. M8 37.66 0.001 0.26 5.46 90, 106, 109, 110, 112, 113, 123, 129, 135, 136,
138, 156, 159, 176, 177
M7 vs. M8 37.74 0.001 0.26 5.46 (same as M8a vs. M8)
‘Higher’ primates M1a vs. M2a 2.29 NS ** ** **
M8a vs. M8 2.29 NS ** ** **
M7 vs. M8 3.05 NS ** ** **
NKG2 ‘Lower’ primates M1a vs. M2a 16.98 0.001 0.15 2.72
M8a vs. M8 17.45 0.001 0.19 2.50 137, 145, 150, 171, 214, 224
M7 vs. M8 24.73 0.001 0.19 2.50 (same as M8a vs. M8)
‘Higher’ primates M1a vs. M2a 7.81 0.05 0.07 3.18
M8a vs. M8 7.43 0.01 0.14 2.52 168
M7 vs. M8 10.02 0.01 0.14 2.52 (same as M8a vs. M8)
Maximum likelihood estimation of dN/dS ratios and detection of positively selected positions for the NKG2 and CD94 lectin-like domain sequences of ‘higher’ and
‘lower’ primates. The results of the likelihood ratio tests (see methods) are indicated on the left side of the panel and the positions detected as positively selected (with
model M8) are listed on the right side of the panel (p.0.95; p.0.99 shown in bold). a, error level to reject the null model that does not allow for positive selection. NS,
not significant. **, Bayesian analysis was not performed when the likelihood ratio tests were not significant. Residues in italics denote allelic substitutions were found at
this site. Amino acid positions and numbering refer to human CD94 and NKG2A sequences and equivalent positions in aligned non-human primate sequences.
doi:10.1371/journal.pgen.1000688.t001
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Because the differences between the genes largely overshadowed
allelic differences in our analysis for positive selection, such an
observation suggests that following gene duplication natural
selection first diversified functional sites and subsequently favoured
in each species polymorphisms at sites often not directly involved in
function, presumably to further ‘tweak’ functions.
Unlike the ligand binding sites, the positions involved in dimer
formation are not significantly enriched in positively selected sites
(Table 2, Figure S6). Because of this apparent lack of major
diversification of the dimer formation function, we hypothesised
that the three CD94 and five NKG2 molecules of the grey mouse
lemur can be freely combined to form various CD94/NKG2
heterodimers. To test this hypothesis, we checked all possible
combinations with (extracellular) V5-tagged NKG2 and (intracel-
lular) GFP-tagged CD94 molecules. Expression constructs were
transiently transfected into 293T cells and CD94/NKG2
heterodimer formation was assayed by co-immunoprecipitation
using tag-specific monoclonal antibodies. Heterodimers were
found for all CD94/NKG2 combinations by co-immunoprecip-
itation (Figure 6). Cell surface expression of all CD94/NKG2
receptor combinations was examined with (both extracellular)
FLAG- and V5-tagged CD94 and NKG2 molecules, respectively.
All combinations of NKG2-1, NKG2-3, and NKG2-8 with the
three CD94 molecules were found on the cell surface (Figure 7A).
In contrast, cell surface expression of both NKG2-2 and NKG2-5
receptors in combination with CD94 molecules was either low
(CD94-1/NKG2-5) or lacking (Figure 7A), suggesting that these
receptors depend on the DAP12 adaptor molecule. An expression
construct of mouse lemur DAP12 with a c-myc-tag was established
and expression was controlled in parallel experiments by
intracellular staining (data not shown). Co-transfection with c-
myc-tagged mouse lemur DAP12 significantly increased cell
surface expression of all combinations formed by CD94/NKG2-
2 and CD94/NKG2-5 heterodimers (Figure 7B). This finding
identifies NKG2-2 and NKG2-5 as classical activating receptors
whose cell surface expression is dependent on interaction with
DAP12. CD94 and NKG2 expression constructs were also
transfected in 293T cells alone. Similar to human CD94, all three
Table 2. Natural selection targeted the CD94/NKG2 residues
interacting with the peptide presented by MHC class I ligands
in ‘‘lower’’ primates.
All
Ligand
binding Dimer Peptide MHC
Total Selected Sites 21 21 21 21 21
Selected Sites in Category 9 7 4 4 5
Total Residues (CD94+NKG2) 239 239 239 239 239
Residues in Category 54 28 30 7 25
exact p 0.021 0.006 0.152 0.003 0.044
cumulative p 0.031 0.008 0.266 0.003 0.061
p ‘‘distribution by chance’’ ,0.05 ,0.01 NS ,0.01 ,0.06
Binomial test to investigate whether positively selected residues are randomly
distributed or are clustered at functionally relevant sites of the molecules.
Several CD94/NKG2 functional categories were considered based on the human
CD94/NKG2A crystal structure [22,23]: residues contacting the peptide
presented by the MHC ligand form the ‘Peptide’ category while those
contacting the MHC class I heavy chain form the ‘MHC’ category; residues
mediating heterodimer formation represent the ‘Dimer’ category. Additionally,
Peptide and MHC contacts (‘Ligand binding’) and all known contact residues
(‘All’) are summarised. Details on the residues in each category are in Figure S6.
doi:10.1371/journal.pgen.1000688.t002
Figure 6. Co-immunoprecipitation of various combinations of
grey mouse lemur CD94 and NKG2 expression constructs. CD94
constructs fused at the NH2 terminus with GFP and NKG2 molecules
tagged at the COOH terminus with the V5 tag were transiently
transfected into 293T cells. Analyses were performed 24h upon
transfection. Representatives of at least three independent experiments
are shown. Differential degree of glycosylation gives rise to multiple
bands. In the lower panel deglycosylation with PNGase F is
demonstrated exemplarily for inhibitory receptor NKG2-3.
doi:10.1371/journal.pgen.1000688.g006
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Figure 7. COOH terminally tagged NKG2 (V5 tag) andCD94 (FLAG tag)molecules were transiently transfected into 293T cells. Analyses
were performed 24 h upon transfection. Representatives of at least three independent experiments are shown. Numbers indicate the percentage of cells
in each quadrant. Cells in the upper right quadrant show V5- and FLAG-double-positive cells. (A) CD94 and NKG2 cell surface expression without co-
expression of DAP12. (B) Enhancement of NKG2-2 and NKG2-5 expression at the cell surface by co-expression of myc-tagged DAP12.
doi:10.1371/journal.pgen.1000688.g007
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mouse lemur CD94 proteins can be found at the cell surface in the
absence of any NKG2 molecule, but unlike human NKG2
molecules, also mouse lemur NKG2-2 (with DAP12) and NKG2-
3, and to a lower extent NKG2-5 (with DAP12) and NKG2-8, are
expressed at the cell surface in the absence of CD94 (Figure 7A
and 7B).
Taken together, our data show that three CD94 molecules can
be combined with five NKG2 molecules to form 15 different NK
cell receptors that display significant diversity at sites of interaction
with MHC class I ligands and their bound peptide. This indicates
that besides gene amplification and positive diversifying selection
combinatorial diversity is also a mechanism that significantly
contributes to the increase of NK cell receptor diversity in ‘lower’
primates.
Discussion
The polymorphic NK cell receptors of humans and mice are
functionally similar but structurally unrelated. Therefore, we
traced back NK cell receptors and MHC class I ligands to the base
of the primate evolutionary tree by analysis of the LRC, NKC, and
MHC genomic regions in primates distantly related to humans. We
demonstrate that ‘lower’ primates deviate from ‘higher’ primates
in the usage of polymorphic NK cell receptors. Except for the
KIR3DX1 gene, lemurs and possibly other ‘lower’ primates have
neither functional nor highly polymorphic KIR genes like their
relatives, the catarrhine (Old World monkeys, apes, and humans)
and platyrrhine (New World monkeys) primates, nor do they show
an expansion of Ly49 genes as in rodents. Instead, lemurs have
considerably amplified and diversified their C-type lectin-like
CD94 and NKG2 genes. We conclude from our findings that the
NK cell receptor repertoire of ‘lower’ primates is at least as diverse
as in ‘higher’ primates or rodents. Thus, in addition to the KIR and
Ly49 genes of ‘higher’ primates and rodents, the CD94/NKG2
heterodimers of lemurs represent a third system of polymorphic
and diverse NK cell receptors. Compatible with such a system is
that the duplicated lemur CD94 and NKG2 genes show sequence
diversifications and strong signs of positive diversifying selection.
In accordance with these characteristics, lemur NKG2 genes do not
show signs of gene homogenisation as opposed to ‘higher’ primate
NKG2 sequences [11]. Such homogenisation may serve to keep
NKG2 amino acid sequences conserved for interaction with the
invariable MHC-E ligand, a situation that is not observed for the
polymorphic CD94/NKG2 receptors in ‘lower’ primates.
CD94 gene duplications are not restricted to ‘lower’ primates
from Madagascar as they were found in an African strepsirrhine
primate (Perodicticus potto) and in the Asian tarsier (Tarsius syrichta).
The latter is particularly interesting, as the tarsier is more closely
related to ‘higher’ primates than to ‘lower’ primates [21]. Analysis
of repetitive elements in CD94 intron 4 sequences revealed that
duplications had occurred repeatedly and independently in ‘lower’
primates. Thus, the polymorphic CD94/NKG2 system is likely
present in many if not all ‘lower’ primates. This is in sharp contrast
to the situation in ‘higher’ primates where CD94 is a single copy,
non-polymorphic and highly conserved gene.
Three KIR genes were detected in the lemur LRC region, a
functional and a pseudogene copy of KIR3DX1 and a KIR3DP
pseudogene. According to its characteristics, the KIR3DP gene
may represent the ‘Ur-KIR’ gene of all ‘higher’ primate KIRs. This
gene already contains the repetitive elements MLTD1, MER70B,
MSTB1 in its introns, which are assumed to be integrated about
60–100 mya [25], a time that is compatible with the splitting of
lemurs and human of about 65–90 mya [26]. Thus, we postulate
that KIR and CD94/NKG2 receptors evolved differently in
primates: while in the lineage leading to ‘lower’ primates CD94
and NKG2 but not KIR genes expanded, the opposite happened in
the lineage leading to ‘higher’ primates where KIR genes expanded
and CD94 and NKG2 co-evolved with the non-classical MHC-E
molecule to become a conserved receptor/ligand system (Figure 8).
The finding that ‘lower’ primates did not amplify and diversify KIR
or Ly49 genes but, instead, evolved a polymorphic CD94/NKG2
system, strengthens previous assumptions that mammals only
utilise a single class of polymorphic NK cell receptors, despite their
obvious ability to develop multiple classes [27,28]. Most likely, this
development is influenced by the pathogenic threat these
organisms are subjected to and can involve different receptor
types such as monomeric KIR, heterodimeric CD94/NKG2, and
homodimeric Ly49. Nevertheless, mammalian species are
equipped with all types of receptor genes [1], which gives some
flexibility for adaptation according to NK cell receptor and ligand
requirements.
All class I genes in the MHC equivalent genomic region on grey
mouse lemur chromosome 6 are pseudogenes and all functional
MHC class I genes were translocated to chromosome 26.
Additionally, no functional MIC gene could be identified in any
of the class I gene-containing regions in the grey mouse lemur.
However, this finding is not surprising, as NKG2D ligands are
numerous and functionally redundant [29], absence of MIC is
evident in rodents [30] and deletions of both MICA and MICB
were reported in East-Asians [31]. In addition to this unusual
organisation of the grey mouse lemurMHC, a striking difference to
‘higher’ primates is the apparent absence of a strict HLA-E
orthologue or functional homologue. As the BAC library was
screened exhaustively and in the light of our genome-wide
approach published earlier [18], it appears rather unlikely that
MHC-E-like class I genes were not detected. Thus, the putative
CD94/NKG2 ligands are expected among the sequenced MHC
class I genes. Nevertheless, we cannot completely rule out the
possibility that a HLA-E-like gene was not detected by our
approach or that a gene with HLA-E-like function is among the
detected MHC class I genes. There has been some debate in the
past on whether HLA-E and mouse H2-Qa1 have a common
origin [32] or whether their similarity in the peptide-binding
region is a consequence of convergent evolution [33]. In the light
of our data, the second hypothesis appears more likely, as
diversified KIR and conserved MHC-E/CD94/NKG2 emerged
only in ‘higher’ primates and diversified Ly49 and conserved H2-
Qa1/CD94/NKG2 evolved independently in rodents.
The observed positive diversifying selection in ‘lower’ primates
is more pronounced in the three CD94 than the NKG2 genes,
suggesting that the CD94 molecules have significant impact on
the binding of the polymorphic MHC class I ligands and their
bound peptides. Indeed, the recently determined three-dimen-
sional structure of human CD94/NKG2A in complex with HLA-
E revealed that CD94 and NKG2A contribute about 80% and
20%, respectively, to the interaction with HLA-E and its bound
peptide [22,23]. Translated to the situation in ‘lower’ primates,
duplication of CD94 genes and their strong sequence diversifica-
tion by positive diversifying selection reflects the requirement to
maintain binding to polymorphic (classical) MHC class I
molecules and bound peptides. Finally, we demonstrate that all
possible CD94/NKG2 combinations are able to form heterodi-
mers at the cell surface, revealing important implications:
exchange of the CD94 or the NKG2 subunit is likely to influence
the binding specificity for MHC class I ligands and their bound
peptide and the functional properties (inhibitory or stimulating) of
the receptor. For example, the combination of the three CD94
and five NKG2 molecules in the grey mouse lemur or three
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CD94 and eight NKG2 molecules in the ruffed lemur gives rise to
15 or 24 different NK cell receptors, respectively. Thus, we
conclude that the NK cell receptor repertoire in ‘lower’ primates
is not mainly achieved by duplications, but rather by combina-
torial diversity, a phenomenon that was so far unknown for any
NK cell receptor. NK cells were recently shown to exhibit
features of adaptive immunity, namely immunological memory
[34]. Combinatorial diversity of immune receptors is a further
hallmark of adaptive immunity. Although the combinatorial
diversity of ‘lower’ primate CD94/NKG2 receptors is obviously
much less than that usually seen for B or T cell receptors, our
data additionally highlight the close relationship of two
lymphocyte subsets: natural killer cells and cytotoxic T cells.
In summary, we have uncovered a ‘third way’ of polymorphic
and diversified NK cell receptors in mammals. The CD94/NKG2
receptor system (and not KIR) of ‘lower’ primates is characterised
by duplication, sequence diversification by means of positive
diversifying selection and allelic diversity. Consistent with this
highly dynamic CD94/NKG2 system, the MHC class I molecules
as putative ligands of these receptors show strong signs of co-
evolution and an unusual chromosomal organisation. CD94 and
NKG2 subunits constitute the main NK cell receptor repertoire in
‘lower’ primates and are freely combinable. This finding discloses
a so far unknown mechanism of generating the NK cell receptor
diversity: combinatorial diversity.
Materials and Methods
Ethics statement
All experiments were carried out in accordance with the French
Rural Code Directive (articles R21-87-90), the German Animal
Welfare Law, guidelines of the German Research Foundation, and
the European Communities Council Directive (86/609/EEC).
Field sampling of Microcebus murinus tissue samples in Madagascar
was conducted under the autorisation of the Ministe`re de
l’’Environnement, des Foreˆts et du Tourisme of the Republic of
Madagascar. Samples were exported under a CITES permit by
the Bundesamt fu¨r Naturschutz, Bonn, Germany.
Blood and DNA samples
Grey mouse lemurs (Microcebus murinus) and black-and-white
ruffed lemurs (Varecia variegata) are housed in the facilities of the
UMR CNRS/MNHN and the German Primate Center, respec-
tively. Blood was obtained during regular veterinary inspections.
DNA samples from potto and tarsier were kindly obtained from
Helga Schulze (University of Bochum, Germany) and Ju¨rgen
Schmitz (University of Mu¨nster, Germany).
BAC library screening and clone sequencing
Filters of BAC library CHORI-257 derived from a female grey
mouse lemur (Microcebus murinus) were obtained from BACPAC
Figure 8. Model of NK cell receptor evolution in primates.
doi:10.1371/journal.pgen.1000688.g008
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Resources at the Children’s Hospital Oakland Research Institute
(http://bacpac.chori.org/home.htm). Filters were screened with
gene probes for human KIR2DL4, LILRA2, NCR1, and rhesus
macaque KIR3DX1 (LRC region), human CD94, NKG2A, and
Ly49L (NKC region), catta BAT1, POU5F1, TCF19, and rat Gnl1,
Cat56, Trim39, Trim26, Trim10, Trim15, Ppp1r11, Mog, and mouse
lemur MHC class I (MHC class I region). Screening with
radioactively labelled probes was done according to the supplier’s
recommendations.
BAC clone DNA was purified by CsCl density centrifugation
and isolated DNA was sheared by sonification. DNA fragments of
1.5–3.5 kb were selected and cloned into plasmid pUC19. Inserts
were amplified by PCR using insert-flanking M13 forward and
reverse primers and amplificates were sequenced with Applied
Biosystems BigDye terminator chemistry and analyzed in
ABI3730xl sequencers (Applied Biosystems). Raw sequences were
processed by Phred (www.phrap.org) and assembled into a
contiguous sequence by Phrap (www.phrap.org). Both programs
are available from Phil Green, University of Washington. Exons
and introns of genes were identified in finished BAC clone
sequences manually or by BLAST and FGENESH-2 algorithms
(http://www.ncbi.nlm.nih.gov/BLAST/; http://www.softberry.
com/all.htm). All BAC clone sequences have ‘finished sequencing’
quality (1 putative mistake/100,000 bases) and the data have
Phred values of 60.
Exons 4 to 6 of the grey mouse lemur CD94, NKG2, and Ly49L
genes were amplified from genomic DNA of 12 (all genes) and
additional 34 (only CD94 genes) unrelated free-living grey mouse
lemur individuals from the Kirindy region in Madagascar. Specific
primers (Table S2) were designed to be located in exon-flanking
introns. PCR products were completely sequenced on both strands
and SNPs were identified.
Primers were designed for amplification of conserved regions of
potto and tarsier CD94 exon 4, intron 4 and exon 5 (Table S2).
Genomic DNA was used of a single potto (Perodicticus potto) and a
single Philippine tarsier (Tarsius syrichta) individual. PCR products
were cloned and sequenced. For every CD94 sequence at least two
identical clones were identified.
DDBJ/EMBL/GenBank database accession numbers for BAC
clones of MHC class I regions (AB480748, FP236831, FP236832,
FP236833, FP236839), NKC region (haplotype 1: FP236838,
haplotype 2: FP236834), LRC region (CR974412, CR974436,
CR974413), and cDNA of grey mouse lemur and ruffed lemur
CD94, NKG2 and Ly49L sequences as well as potto and tarsier CD94
sequences were assigned accession numbers FJ869057-FJ869114.
Grey mouse lemur KIR3DX1 and DAP12 cDNA sequences are
found under FJ882074-FJ882079.
RT–PCR and expression constructs
Total RNA was extracted from a liver sample of a grey mouse
lemur and a blood sample from a further grey mouse lemur housed
at UMR CNRS/MNHN in Brunoy (France) and a blood sample
from a black-and-white ruffed lemur (Varecia variegata variegata)
housed at the German Primate Center. Reverse transcription was
performed with M-MLV reverse transcriptase (Promega). Based on
the mouse lemur BAC sequences primers were designed to obtain
the complete open reading frames of mouse lemur and ruffed lemur
NKC genes. cDNA sequences of the ruffed lemur were completed by
59- and 39-RACE PCR with the GeneRacer Kit (Invitrogen). All
cDNA sequences were cloned and sequenced. For interaction
studies, grey mouse lemur CD94 and NKG2 cDNA sequences were
inserted into the pcDNA3.1/NT-GFP-TOPO and the pcDNA3.1/
V5-His-TOPO vector (Invitrogen), respectively. For cell surface
expression, the three CD94 cDNA sequences were expressed
without GFP at the NH2 terminus, but with a FLAG tag
(DYKDDDDK) at the COOH terminus for extracellular detection.
The grey mouse lemur DAP12 cDNA was isolated by RT-PCR.
The encoded DAP12 was fused at the COOH terminus with the c-
myc peptide epitope (EQKLISEEDL). Primer sequences and
performed PCRs are listed in Table S2.
Transfection, co-immunoprecipitation, and flow
cytometry
CD94 and NKG2 molecules were tagged with GFP and with
V5 for co-immunoprecipitation experiments. To avoid any
potential unwanted interactions between the tags, GFP was fused
to the amino terminus of CD94 ( = intracellular localisation) and
V5 to the carboxy terminus of NKG2 molecules ( = extracellular
localisation). Expression constructs were transiently transfected in
the human 293T cell line using Metafectene (Biontex GmbH).
24 h after transfection, cells (16107 cells/ml) were lysed in NP-40
lysis buffer containing 0.1% NP-40, 50 mM Tris, pH 7.6,
150 mM NaCl, 4 mM EDTA and protease inhibitors (Roche).
Lysates were incubated overnight at 4uC with monoclonal mouse
anti-GFP antibody (Clontech) and then incubated with protein G
Sepharose 4 Fast Flow beads (GE Healthcare) for 3 h. Sepharose
beads were washed five times with lysis buffer and bound proteins
were eluted with loading buffer at 95uC for 10 minutes. Samples
were electrophoresed in 10% polyacrylacrylamide gels and
transferred to nitrocellulose membrane. Western blotting was
performed with HRP-coupled monoclonal mouse anti-V5 anti-
body (Invitrogen) to test for co-immunoprecipitated V5-tagged
NKG2 molecules. Deglycosylation was performed with PNGase F
according to supplier’s recommendations (New England Biolabs).
For analysis of CD94/NKG2 receptors on the cell surface,
CD94 was FLAG-tagged at the carboxy terminus ( = extracellular
localisation). Respective expression constructs of CD94 together
with the V5-tag NKG2 constructs (see above) were transiently
transfected in 293T cells. Cell surface expression of CD94/
NKG2-2 and CD94/NKG2-5 receptors were tested by additional
transient transfection with c-myc-tagged mouse lemur DAP12
expression constructs. As control, single transfections with either
CD94 or NKG2 expression constructs were performed. Potential
formation of heterodimers of grey mouse lemur NKG2 and
human CD94 (from 293T cells) was excluded by testing with an
anti-human CD94 antibody (AbD Serotec). 24 hours post
transfection cells were detached from cell culture dishes and
washed twice with 16PBS. Cells were stained with APC-labelled
anti-V5 (Abcam) and FITC-labelled anti-FLAG (Sigma-Aldrich)
monoclonal antibodies for surface expression of NKG2 and
CD94. In parallel experiments, expression of DAP12 was
monitored with an anti-c-myc mouse monoclonal antibody
(Sigma-Aldrich) by intracellular staining of cells, which were
previously fixed with 1.5% paraformaldehyde (Merck) and
permeabilized with 0.25% saponin (Roth), and binding was
detected by a PE-Cy5-labelled goat anti-mouse IgG polyclonal
antibody (Santa Cruz Biotechnology). After washing twice with 16
PBS cells were resuspended in 200 ml of 16 PBS and 50,000
events were measured. Living cells were gated based on forward
and side scatter characteristics and analysed for APC and FITC
staining. All samples were analysed in a LSRII flow cytometer
(BD). Data were acquired with BD FACS Diva 5.1 software (BD)
before analysis with FlowJo 7.2.9 software (TreeStar).
Phylogenetic analyses
CD94, NKG2 andMHC class I nucleotide sequences were aligned
with MAFFT [35] and corrected manually. Phylogenetic analyses
were conducted using three methods: neighbor-joining (NJ),
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parsimony and Bayesian phylogenetics. NJ analyses were per-
formed with MEGA3.1 [36] using the Tamura-Nei method with
1,000 replicates. PAUP*4.0b10 [37] and the tree bisection-
reconnection branch swapping algorithm were used for parsimony
analyses with 1,000 replicates and a heuristic search. For the
Bayesian analysis, the model of DNA substitution was selected
using MODELTEST3.7 [38] and the Akaike information
criterion. Bayesian phylogenetic analyses were conducted with
MRBAYES3.1.2 [39]; sampling was performed with one cold
chain and three heated chains, which were run for 106 generations
or until average standard deviation of split frequencies was ,0.01.
Trees were sampled every 200 generations and the first 2,500 trees
were discarded before a consensus tree was generated; three
simultaneous runs were conducted and average standard deviation
of split frequencies was always ,0.01. The tree topologies
obtained with the three methods were compared with
PAUP*4.0b10 using the Shimodaira-Hasegawa test of alternative
phylogenetic hypotheses with re-sampling estimated log-likelihood
optimization, and 10,000 bootstrap replicates; in all analyses the
test failed to reject any of the alternative tree topologies (a=0.05).
This comparison was made with the maximum likelihood model
defined by MODELTEST. A maximum-likelihood analysis was
also performed for the study of the NKG2 cytoplasmic and
transmembrane sequences using RAxML7 [40] under the
GTR+CAT model with 1,000 replicates (rapid bootstrapping).
Selection analyses
dN/dS (v) ratios for CD94 and NKG2 lectin-like domains were
estimated using PAML v3.15 [41] with the F3 X 4 model of codon
frequencies. Bayesian tree topologies were used for these analyses
and three sets of likelihood ratio tests were conducted to compare
null models that do not allow v.1 (M1a, M7 and M8a) with
models that do (M2a and M8). Significance was assessed by
comparing twice the difference in likelihood between the models
(2DL) to a x2 distribution with one (M8a/M8) or two (M1a/M2
and M7/M8) degrees of freedom. Codons with v.1 were
identified using the Bayes Empirical Bayes approach [42].
The distribution of the selected sites in the CD94/NKG2 lectin-
like domains was studied using a binomial distribution: considering
V= (0,1,2,…,n), "k M V, p = (X= k) = nCk * pk * qn2k. This
indicates for example that under a random distribution it is
unlikely to have more than 5 of the 21 positively selected sites in
the ligand binding region that represents 28 of the 239 total sites
(a=0.05); so the fact that we observe 7 of the 21 positively selected
sites in this region indicates a distribution biased toward this region
(a =0.01).
Supporting Information
Figure S1 Mouse lemur KIR3DX1 sequence. (A) cDNA, (B)
deduced amino acid sequence and (C) genomic sequence. cDNA
sequence was determined by RT-PCR of mouse lemur PBMC.
Start codon is marked in green, stop codon in red, exons in grey,
and ITIM in the protein sequence in yellow. Nucleotides and
corresponding amino acid residues that are absent in an
alternatively spliced product are shown in italics. Transmembrane
region is underlined.
Found at: doi:10.1371/journal.pgen.1000688.s001 (0.04 MB PDF)
Figure S2 Multiple sequence alignments of CD94 proteins. (A)
Multiple sequence alignment of mouse lemur, ruffed lemur,
human, and common marmoset CD94 proteins. Sequences are
subdivided into cytoplasmic (CY), transmembrane (TM), stalk, and
C-type lectin-like domain (CTLD). (B) Amino acid sequence
identities (in %) of mouse lemur, ruffed lemur, human and
common marmoset CD94. Mimu, Microcebus murinus; Vava, Varecia
variegata; Hosa, Homo sapiens; Caja, Callithrix jacchus.
Found at: doi:10.1371/journal.pgen.1000688.s002 (0.01 MB PDF)
Figure S3 Multiple sequence alignments of NKG2 proteins. (A)
mouse lemur and (B) ruffed lemur NKG2 and Ly49L amino acid
sequences. Sequences are subdivided into cytoplasmic (CY),
transmembrane (TM), stalk, and C-type lectin-like domain
(CTLD). ITIM are highlighted in green, YxxM motif in yellow
and positively charged amino acids in the TM in red. An ITIM at
unusual position was found in mouse lemur NKG2-5 and is
marked in blue. It is not clear whether this motif functions as an
ITIM. Due to failure of obtaining a 59-RACE product for ruffed
lemur Ly49L, the corresponding deduced amino acid sequence is
incomplete at the amino terminal end. The two identified ruffed
lemur Ly49L alleles show only a single synonymous substitution
and have therefore identical deduced amino acid sequences.
Mimu, Microcebus murinus; Vava, Varecia variegata.
Found at: doi:10.1371/journal.pgen.1000688.s003 (0.02 MB PDF)
Figure S4 CD94 exon 4 to exon 5 sequence alignment of (A)
potto (Perodicticus potto) and (B) Philippine tarsier (Tarsius syrichta).
The shading threshold is 55% sequence identity. N in the
sequences of potto CD94-6 and -7 and of tarsier CD94-9 denotes
an unknown number of thymidine nucleotides. The CD94-7
sequence of the tarsier contains a stop codon in exon 4 which is
highlighted in bold and underlined. Pepo, Perodicticus potto; Tasy,
Tarsius syrichta. Alu elements are underlined.
Found at: doi:10.1371/journal.pgen.1000688.s004 (0.03 MB PDF)
Figure S5 Phylogenetic analyses of MHC class I genes with
complete coding sequences excluding the peptide binding residues.
Analysis and display are as described for Figure 3. Numbers as gene
names for MHC class I are the same as in Figure 1C. Non-primate
sequences included are mouse (H2) and rat (RT1). Peptide binding
residues were defined according to Bjorkman et al. [44]. Patr, Pan
troglodytes; Gogo, Gorilla gorilla; Hyla,Hylobates lar; Saoe, Saguinus oedipus;
Sasc, Saimiri sciureus; Mamu,Macaca mulatta; Mimu,Microcebus murinus;
Aotr, Aotus trivirgatus; Caja, Callithrix jacchus; Pipi, Pithecia pithecia.
Found at: doi:10.1371/journal.pgen.1000688.s005 (0.07 MB PDF)
Figure S6 Contacts of CD94/NKG2 to bound peptide (Peptide)
and to the MHC class I heavy chain (MHC) as well as residues
mediating heterodimer formation (Dimer) based on the human
CD94/NKG2A crystal structure [22,23]. Additionally, Peptide
and MHC contacts (Ligand binding) and all known contact
residues (All) are summarised.
Found at: doi:10.1371/journal.pgen.1000688.s006 (4.54 MB TIF)
Table S1 Nucleotide and amino acid substitutions between
different alleles of mouse lemur CD94, NKG2, and Ly49L
sequences. SNPs were determined by sequencing the exons coding
for the lectin-like domain (exon 4–6) of 12 individuals for NKG2
and Ly49L. For CD94 a further 34 animals were analysed.
Found at: doi:10.1371/journal.pgen.1000688.s007 (0.04 MB PDF)
Table S2 Primer sequences and performed PCRs.
Found at: doi:10.1371/journal.pgen.1000688.s008 (0.08 MB PDF)
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